BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. [Yahoo! Finance]
CureVac N.V. - Ordinary Shares (CVAC)
Company Research
Source: Yahoo! Finance
of its acquisition of CureVac N.V. (NASDAQ:CVAC), which is another mRNA-focused biotech firm from Mainz, Germany. Management noted that the deal had closed after the expiration of the subsequent offering period in exchange for CureVac's shares. As a result, the company now holds a majority stake in CureVac. This enables the company to integrate CureVac's pipeline for oncology and infectious diseases. In another update, on December 11, H.C. Wainwright reiterated a Buy rating on BioNTech SE (NASDAQ:BNTX) with a $140 price target. The bullish sentiment is based on the interim data from a Phase 2 trial testing Pumitamig (BNT327/BMS-986545), which is a bispecific antibody that targets both PD-L1 and VEGF-A. The treatment is being tested for patients with triple-negative breast cancer (TNBC). The results showed strong anti-tumor activity and tolerable safety. Management noted that the results support advancing to a Phase 3 trial called ROSETTA-BREAST-01. H.C. Wainwright noted that t
Show less
Read more
Impact Snapshot
Event Time:
CVAC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CVAC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CVAC alerts
High impacting CureVac N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CVAC
News
- CureVac (NASDAQ:CVAC) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- CureVac (NASDAQ:CVAC) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- CureVac (NASDAQ:CVAC) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- CureVac N.V. (CVAC): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- CureVac (NASDAQ:CVAC) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d-)" rating.MarketBeat
CVAC
Earnings
- 11/24/25 - Beat
CVAC
Sec Filings
- 12/18/25 - Form SC
- 12/18/25 - Form SC
- 12/12/25 - Form SCHEDULE
- CVAC's page on the SEC website